December 24, 2025 - 19:11

Ronald Deibert and his research group, Citizen Lab, have dedicated the last two decades to exposing significant digital threats that lurk within our smartphones and other devices. With a focus on identifying and analyzing spyware and surveillance technologies, Deibert has become a pivotal figure in the fight for digital rights and privacy. His team’s investigations have revealed how various entities exploit technology to infringe upon personal freedoms and privacy.
However, Deibert now raises concerns about the future of this vital work. He emphasizes that the ongoing efforts to unveil these threats are increasingly at risk due to a combination of political pressures, funding challenges, and the rapid evolution of technology. As governments and corporations invest heavily in surveillance tools, the need for independent research becomes ever more critical. Deibert's commitment to safeguarding digital rights highlights the importance of vigilance in an age where our devices may be compromised by malicious actors.
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...